Detecting episomal or integrated human papillomavirus 16 DNA using an exonuclease V-qPCR-based assay

Area of Science:

• Molecular Biology
• Virology
• Cancer Research

Background:

• Human papillomavirus (HPV) integration into host cell DNA is crucial for cancer development.
• Current methods for detecting HPV integration are time-consuming and reagent-intensive.
• Accurate determination of HPV genome status (episomal vs. integrated) is vital for understanding HPV-associated cancers.

Purpose of the Study:

• To develop a rapid, sensitive, and accurate assay for determining HPV genome configurations.
• To differentiate between episomal and integrated forms of HPV DNA.
• To establish a method applicable to both cell lines and tissue samples.

Main Methods:

• Utilized exonuclease V (ExoV), an enzyme specific for linear DNA.
• Developed a quantitative polymerase chain reaction (qPCR) assay to measure DNA resistant to ExoV digestion.
• Established the assay using genomic DNA from cell lines with known HPV16 integration status.

Main Results:

• The ExoV-qPCR assay accurately distinguished between integrated and episomal HPV16.
• The assay demonstrated sensitivity and specificity in cell lines and tissue samples.
• The method provides a quantitative measure of HPV DNA resistance to ExoV digestion.

Conclusions:

• The ExoV-qPCR assay offers a rapid and sensitive alternative for screening HPV genome configurations.
• This assay can reliably differentiate episomal from integrated HPV DNA.
• Potential applications include studying HPV genome dynamics in cancer progression.